Reed Smith LLP’s corporate team, in close collaboration with the firm’s specialized groups in life sciences, finance, entertainment, and technology, offers end-to-end services to emerging companies from inception, incorporation, and funding to exit strategies. This integrated approach allows the firm to support venture capital and private equity investors in innovative areas such as AI-powered software, NFTs, and Web 3.0 technologies. Co-leading the practice, Michael Sanders in Los Angeles is dedicated to life sciences clients involved in medical devices, pharmaceuticals, and drug discovery, while Silicon Valley’s Donald Reinke is experienced in the financing of emerging tech companies, representing issuers, private equity clients, and venture capital funds. In Silicon Valley, Craig Lilly counsels tech entities on venture capital and debt financings, IPOs, and joint ventures. LiLing Poh left the firm in September 2023.
Testimonials
Collated independently by Legal 500 research team.
‘What I like about the emerging companies practice at Reed Smith is that my "quarterback" Michael Sanders has seen just about everything in his long-tenured career in this space - but he's not afraid to bring in specialists when a particular issue isn't directly in his wheelhouse.'
‘Michael Sanders always makes me feel like the issues he's helping me with are the most important ones on his docket. Mattias Luukkonen is very knowledgeable in his specialty area (corporate partnering), and very practical in his approach to negotiations.'